GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
658
c/glp1science·posted 1 year ago by u/camila_kowalski

receptor: the version I wish someone had shown me in week 1

Speculation Receipts ×5

Confession thread, sort of.

I went from 1.0mg to 15mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 8 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway.

So now I have early fullness I did not need and a data point I cannot interpret. Two lessons in one.

Posting it in the hope that somebody at week 64 reads it before doing the same thing.

871 up / 213 down80% upvoted15 commentsid 1sgeno27 Apr 2025

15 comments

10 in this archive, depth 6

best — the order this archive was captured in

u/anya_salgado161 points·1 year ago

This is correct. Rodent data is investigational, not predictive.

replysharereportpermalink
u/camila_kowalskiOP188 points·1 year ago

Where does the half-life data actually come from?

replysharereportpermalink
[removed]84 points·1 year ago

[removed by moderator]

replysharereportpermalink
u/laila_almeida52 points·1 year ago

central appetite signalling is real but people overweight it

replysharereportpermalink
u/tomas_broberg20 points·1 year ago

Disagree but this is the good kind of wrong — it is specific enough to be checked.

replysharereportpermalink
u/rina_bergstrom85 points·1 year ago

Yeah, the incretin mechanism is doing the work here.

replysharereportpermalink
u/yannick_barros46 points·1 year ago

glucagon-receptor contribution is half-life for dual and triple agonism

replysharereportpermalink
u/amara_dziedzic20 points·1 year ago

glucagon-receptor contribution is pharmacology for dual and triple agonism

replysharereportpermalink
u/ingrid_correia5 points·1 year ago

Strongly agree. Central appetite is real but people overstate it.

replysharereportpermalink
u/hassan_castellanos114 points·1 year ago·edited

The half-life is 18 hours, which means week 18 is genuinely still ramp-up. Week 22 is steady state.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.